Tydra Labs raises ~$422K to turn food waste into biomaterials

What's the deal? Vancouver's Tydra LabsDealroom has a profile for this one. Try Dealroom → has raised US$440K (roughly $422,000) from NorthX to push its plant-based chitin biomaterials toward pilot manufacturing. The startup previously raised US$880K, bringing total funding to US$1.32M.

What's the endgame? Tydra cultivates its flagship ingredient, TYDRA ONE, from food streams. The material retains a hydrated, fibrous structure that can support thickening, emulsification, and other functions.

What's the product? Cosmetics is the startup's first target market, with potential applications in agriculture, packaging, and biomedical products. The new capital funds manufacturing capabilities and customer relationships for expansion.

What could go wrong? Co-founder Jaiya Varshney says commercialisation requires a deliberate intellectual property strategy. Working with Oyen WiggsDealroom has a profile for this one. Try Dealroom →, Tydra is balancing patents, trade secrets, and brand protection around its core platform.

The signal: By turning food waste into functional ingredients, Tydra is betting that biomaterials can replace conventional inputs across multiple industries — starting small, in cosmetics, before scaling into larger markets.

Read more: decoder.ca

Image credit: Jnzl's Photos